In this respect, a recent systematic review summarizing data from 44 patients with ICI‐induced GCA revealed that most individuals developing GCA after ICI treatment were receiving PD‐1/PD‐L1 blockers (57%).23 The gene discussed is PDCD1; the disease is temporal arteritis.